IART 250117 25.00C (IART250117C25000) Stock Options, News & Quotes

US OptionsDetailed Quotes

IART250117C25000

Watchlist

0.35
0.000.00%

15min DelayTrading Jan 17 16:00 ET

0.00High0.00Low

Intraday

5D
Daily

News

Is Integra LifeSciences (IART) Stock Undervalued Right Now?
Yahoo FinanceJan 22 09:40 ET
5 Price-to-Book Value Stocks With Great Prospects
Zacks Jan 21 14:10 ET
4 Intriguing Value Stocks to Add to Your Portfolio Now
Zacks Jan 20 09:35 ET
Dura Substitutes Market Analysis Report 2025, With Leading Player Analysis for Medtronic, B. Braun, Stryker, DePuy Synthes, Acera Surgical, Severn Healthcare Technologies, Integra Lifesciences & Gunze
Yahoo FinanceJan 15 05:56 ET
Integra LifeSciences Launches Integra Institute for Healthcare Professionals (HCPs)
GlobeNewswireJan 14 08:30 ET
BTIG Maintains Integra Lifesciences(IART.US) With Hold Rating
Moomoo NewsJan 7 18:31 ET · Ratings

Comments

Money Mover

Jul 1, 2024 10:35

Going to miss guidance/earnings

$Integra Lifesciences (IART.US)$ its a buy at $24

Money Mover

Jun 27, 2024 14:20

$Integra Lifesciences (IART.US)$ Integra LifeSciences Price Target Cut to $25.00/Share From $45.00 by Wells Fargo

Moomoo AI

Feb 11, 2024 08:35

EPS growth doesn't align with share price, indicating it may not reflect business performance or growth expectations may have been high. Integra LifeSciences Holdings' performance led to a 3% annual loss for shareholders over five years. Investors should note 3 warning signs.

While Shareholders of Integra LifeSciences Holdings (NASDAQ:IART) Are in the Red Over the Last Three Years, Underlying Earnings Have Actually Grown

Moomoo AI

Jan 29, 2024 04:30

Insider transactions suggest a positive outlook for Integra LifeSciences Holdings, with insiders net buying the stock. The level of insider ownership indicates a reasonable degree of alignment with shareholder interests.

Several Insiders Invested In Integra LifeSciences Holdings Flagging Positive News

Moomoo AI

Jan 15, 2024 05:36

Integra LifeSciences Holdings trades at a low price, suggesting a buying opportunity. Higher cash flow is expected, potentially boosting share valuation. The positive outlook seems not fully factored into the share price, indicating it's not too late to buy IART.

At US$42.94, Is Integra LifeSciences Holdings Corporation (NASDAQ:IART) Worth Looking At Closely?